FDA Calls Off Closed Hearing On Blood Substitute

Law360, New York (July 14, 2006, 12:00 AM EDT) -- Cowed by a consumer group lawsuit to open a closed-door meeting, the Food and Drug Administration decided to postpone Friday’s hearing to discuss the U.S. Navy’s proposition to proceed with a blood substitute trial.

The FDA said Thursday that the advisory panel meeting would be switched to an open meeting at a later date after consumer group Public Citizen’s Health Research Group filed a lawsuit Wednesday in the U.S. District Court for the District of Columbia demanding the agency either cancel the meeting or open it...
To view the full article, register now.